PATENT CLAIM ANALYSIS

Application Number: 15933619
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "140100"]

Abstract:
Disclosed is a method for treating of Cockayne Syndrome (CS). Specifically, the invention pertains to a method for the extracorporeal treatment of a body fluid by removing the body fluid from a living body diseased with CS, and applying a targeted antibody conjugated to a moiety to at least one Cockayne Syndrome antigen in the body fluid, creating an antibody-antigen moiety complex, removing antibody-antigen moiety complex from the body fluid, and returning the purified body fluid to the body.

Claim (Index 15):
The method of  claim 1  further comprised of adding one or more therapeutic agents to the body fluid, wherein the one or more therapeutic agents are at least one member selected from the group consisting of:\n recombinant ERCC1, recombinant ERCC4, recombinant ERCC5, recombinant ERCC8, recombinant ERCC6, and recombinant KIAA1530.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.91304
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15647850', '14978910', '09562245', '13254855', '10461885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6383040287052654
- 35 USC 102 Novelty (BERT): 0.4937286319057644
- Combined Prediction Score: 0.6238464890253153
- Mean Citation Score: 130.47465
- Max Citation Score: 132.54641999999998
- Similarity Product: 81.1604138557112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test